[at noodls] – More news 2013-12-02 Sobi’s partner receives notification of PDUFA extension for ALPROLIX Swedish Orphan Biovitrum AB’s (publ) (Sobi) partner Biogen Idec announced today that the U.S. Food and Drug Administration …
Read more on this.
Biogen Idec Inc. … [visit site to read more]Similar posts:
- Company Update – Bristol-Myers Squibb Company (NYSE:BMY) – Xigduo™ (dapagliflozin and metformin hydrochloride) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
- Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – December 27th Options Now Available For Biogen Idec (BIIB)
- Wal-Mart extends equity conversion date in India’s Cedar – Wal-Mart (WMT)